The Trump administration Monday put forward a series of guidelines for testing and rapid response programs in anticipation of reopening the nation’s economy.

The effort is meant to be a partnership between federal, state, local and tribal governments and the private sector. The federal government will support state-based efforts by expanding the number of testing platforms, increasing testing and laboratory supplies and capacity, and enhancing sample collection.

As part of the effort, the Centers for Disease Control and Prevention updated its evaluation and laboratory testing criteria, stating that “increasing testing capacity will allow clinicians to consider COVID-19 testing for a wider group of symptomatic patients and persons without symptoms in certain situations.”

The following remain high priorities for COVID-19 testing:

  • hospitalized patients;
  • health care facility workers, workers in congregate living settings and first responders with symptoms;
  • residents in long-term care facilities or other congregate living settings, including prisons and shelters, with symptoms; and
  • individuals identified through public health cluster and selected contact investigations.

A second, priority tier was established for individuals with symptoms for potential COVID-19 infection, along with those who are without symptoms who are prioritized by health departments and clinicians based on state and local plans

Related News Articles

Headline
The Food and Drug Administration Aug. 22 granted emergency use authorization for two new combined COVID-19 and influenza tests. The Nano-Check Influenza-COVID-…
Headline
The Centers for Disease Control and Prevention's COVID-19 data tracker shows an 18.1% test positivity rate for the week ending Aug. 10, the highest it has been…
Headline
The Centers for Disease Control and Prevention Aug. 13 issued an advisory alerting of an uptick of cases of parvovirus B19 across the U.S. Parvovirus B19 is a…
Blog
The RAND Corporation recently released the fifth iteration of its biannual hospital price report. The AHA has previously highlighted significant flaws with…
Headline
Adults age 65 and older are encouraged to receive an updated dosage of the COVID-19 vaccine, the Centers for Disease Control and Prevention announced April 25…
Headline
The Pfizer and Moderna COVID-19 vaccines can cause myocarditis, but do not appear to cause infertility, Guillain-Barré syndrome, Bell’s palsy, thrombosis with…